SANGAMO THERAPEUTICS (SGMOQ) Stock Price, News & Analysis
Price Move History
- Daily moves over 5%
- 26 56 sessions, June 24, 2026 to September 11, 2026
- Largest daily move
- +31.4% close of July 2, 2026
Company Description
SANGAMO THERAPEUTICS (OTC: SGMOQ) is classified in the biotechnology industry within the Healthcare sector and carries a market capitalization of $61.5M.
SGMOQ has gained 2.4% over the past month. The last closing price was $0.1485.
For FY2025, SANGAMO THERAPEUTICS reported revenue of $39.6M with net income of -$122.9M and diluted earnings per share of -$0.44. The company operates at a net profit margin of -310.8%.
This page collects what Stock Titan holds for SGMOQ, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
SANGAMO THERAPEUTICS (SGMOQ) closed at $0.1485 on September 11, 2026. Over the past month, the price has gained 2.4%.
SGMOQ Metrics & Rankings
Price returns through September 11, 2026. Month-to-date and YTD include the first trading day. Ranking links may use different dates.
Latest News
SEC Filings
SANGAMO THERAPEUTICS has filed 5 recent SEC filings, including 3 Form 8-K, 1 Form NT 10-Q, 1 Form SCHEDULE 13G/A. The most recent filing was submitted on September 8, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all SGMOQ SEC filings →
Financial Highlights
SANGAMO THERAPEUTICS generated $39.6M in revenue in FY2025, operating income reached -$121.2M (-306.5% operating margin), and net income was -$122.9M, reflecting a -310.8% net profit margin. Diluted earnings per share stood at -$0.44. The company generated -$97.2M in operating cash flow. With a current ratio of 0.84, short-term liquidity bears monitoring.
Upcoming Events
Short Interest History
Short interest in SANGAMO THERAPEUTICS (SGMOQ) currently stands at 9.9 million shares, down 3.9% from the previous reporting period, representing 2.4% of the float. Since June 2026, short interest has decreased by 37.5%. This relatively low short interest suggests limited bearish sentiment.
Days to Cover History
Days to cover for SANGAMO THERAPEUTICS (SGMOQ) currently stands at 1.1 days, down 49.3% from the previous period. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed. The ratio has shown significant volatility over the period, ranging from 1.0 to 2.3 days.
SGMOQ Company Profile & Sector Positioning
SANGAMO THERAPEUTICS (SGMOQ) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the OTC.